Cysteines 265 and 287 of Pseudomonas aeruginosa exotoxin A (ETA) were substituted by serine, thereby eliminating a disulfide bridge within domain II, the putative membrane insertion-translocation domain. Purified mutant toxin was 80-fold less toxic for mouse L cells than was wild-type ETA while retaining the same specific activity in the ADP-ribosyltransferase reaction as did wild-type toxin. Binding of the nonionic detergent Triton X-114 by mutant ETA occurred at a slightly higher pH than did binding by wild-type ETA, suggesting that the mutant protein more readily undergoes a conformational change exposing hydrophobic regions. Data are presented supporting the notion that the mutant and wild-type toxins enter from the same intracellular compartment. The lower cytotoxicity of the mutant protein could be due to accelerated intracellular degradation or abortive, premature membrane insertion.
Pseudomonas aeruginosa exotoxin A (ETA) kills eucaryotic cells by catalyzing the ADP ribosylation of elongation factor 2 within the cytosol (14) . The mechanism whereby ETA enters the cytosol is poorly understood. Indeed, the mechanism by which any protein translocates through highly hydrophobic lipid bilayer membranes is not understood in detail. Toxic proteins such as Pseudomonas ETA and diphtheria toxin are useful model proteins in studies of translocation mechanisms because their entry can be measured by their effects on protein synthesis once they are inside the cytosol.
ETA is known to act by a multistep mechanism, beginning with binding to receptors on the cell surface (18) . The toxin is endocytosed from coated pits and possibly transferred to the Golgi apparatus (20) . It has been documented that low intravesicular pH is required for efficient entry of the toxin (9, 24) . Sandvig and Moskaug (22) reported that Pseudomonas toxin binds Triton at low pH in a similar manner to that of diphtheria toxin. Farahbakhsh et al. (8) described an increase in intrinsic fluorescence of ETA as well as increased binding of the fluorophore 1-anilino-8-naphthalene sulfonic acid with decreasing pH. Low pH is therefore believed to affect the translocation of ETA by triggering a conformational change in the toxin whereby normally hidden hydrophobic regions are exposed. This acquisition of hydrophobic properties is probably crucial for the insertion-translocation process. The translocation results in transfer of at least the catalytic domain to the cytosol and thereby promotes ADP ribosylation of elongation factor 2.
The X-ray crystallographic structure of the toxin shows three domains (1) . Domain I has been identified as the receptor-binding moiety (12, 13) and domain III as that responsible for enzymatic activity (11, 18) . Data indicating that domain II is involved in membrane insertion and translocation have been presented (13) .
To probe the process of membrane insertion and translocation, we have begun to apply directed mutagenesis to the cloned gene. As a first step, we chose to probe the function of the disulfide bridge within domain II (Cys-265-Cys-287). This disulfide, one of the four within ETA, connects two of the six alpha helices comprising domain II. We hypothesized that the disulfide provides a conformational constraint on the molecule and that its removal might influence the conformational change at low pH. ADP ribosylation assays. Samples were assayed for ADP ribosylation activity essentially as described by Lory and Collier (16) EDTA-1 mM dithiothreitol in a final volume of 100 lI. The assay mixture was precipitated on filter paper saturated with 10% trichloroacetic acid, and the paper was washed twice for 30 min with 5% trichloroacetic acid. Finally, the filtered paper was soaked in methanol for 5 min, dried, and counted in a scintillation counter.
MATERIALS AND METHODS
Antiserum preparation. Serum from immunized rabbits or sheep was purified as described previously (6) .
Polyacrylamide gel electrophoresis and Western blots (immunoblots). Polyacrylamide gel electrophoresis was performed in the presence of sodium dodecyl sulfate (SDS) by the procedure described by Laemmli (15) . Samples were analyzed for total protein by Coomassie blue staining (7) or for ETA-related material by immunoblot analysis (25) . Western blots were probed with 125I-labeled rabbit anti-ETA and exposed to X-ray film (X-Omat AR; Eastman Kodak Co., Rochester, N.Y.) for 1 to 24 h. When bands were to be quantified, the film was preflashed and an LKB laser densitometer was used.
Cytotoxicity assay. Mouse L cells (L-M929) were used in cytotoxicity assays in 24-well Falcon plates at a density of 105 cells per ml. Cells were grown in minimal essential medium with 5% fetal bovine serum. At the start of the experiment, the medium in the well was aspirated, and 0.5 ml of the same medium (unless otherwise indicated in the figure legend) was added. Toxin was added, and the cells were incubated at 37°C for 6 h in the presence of 5% CO2 unless otherwise indicated. At Immunoaffinity purification of the mutant was performed as described by C. M. Douglas and R. J. Collier (manuscript in preparation). Immunoglobulin G fractions from ETAimmunized rabbit and sheep sera were prepared as described elsewhere (6) . Antibodies were coupled to Affigel 10 (BioRad Laboratories, Richmond, Calif.) as specified by the manufacturer. Immunoglobulin G-reacted resin (100 ml) was packed, and the supernatant fraction from the sonicated cell suspension was circulated through the affinity column for 2 to 3 h. Unbound protein was washed from the column with 5 (27) . The mutagenesis was performed in two steps, and DNA sequence analysis of plaque-purified M13 mutants confirmed the base changes.
A BglII-ApaI restriction fragment from mutant M13 replicative form was exchanged for the corresponding wild-type fragment in pCDPT2. The resulting plasmid, pCDPTC265SC 287S, encoded the Ser-265/Ser-287 form of ETA. A clone that produced full-length cross-reacting material, as detected by Western blot analysis, was chosen for further study.
Purification of the mutant toxin. Ser-265/Ser-287 ETA was purified from E. coli JM103 bearing the plasmid pCDPTC265 SC287S. Douglas and Collier (in preparation) found that wild-type ETA produced in E. coli comigrated with ETA produced in Pseiudomonias aerlugintosai on a denaturing polyacrylamide gel and that the toxin was stable and had the same cytotoxicity and specific ADP-ribosyltransferase activity as did ETA produced in P. (ireiigi,iosti.
The cellular extract from a fermentor batch of 10 liters was sonicated and centrifuged. The supernatant fraction was chromatographed on an immunoglobulin G immunoaffinity column; the toxin eluted with a high concentration of KSCN, as described by Douglas and Collier (in preparation). Douglas and Collier showed that relative to immunoreactivity, the enzymatic and cytotoxic activities of wild-type ETA remained constant throughout this purification, indicating that the toxin was not inactivated by the purification.
The semipurified toxin preparation (containing most of the degradation fragments as well as some immunoglobulin G from the immunoaffinity column; Fig. 1 ) was then further purified on an FPLC anion-exchange column. The product at this stage was almost 50%c pure (Fig. 1) . A degradation fragment of approximately 40,000 daltons, which we were unable to remove by anion-exchange chromatography, was separated from full-length mutant ETA on an FPLC sizing column. This step yielded material of >95%c purity, as judged by Coomassie staining of the preparation run on an 11.25% SDS-polyacrylamide gel (Fig. 1) Characterization of the purified mutant toxin. (i) ADPribosyltransferase activity. Mutant toxin treated with dithiothreitol and urea had the same ADP-ribosyltransferase activity as did wild-type toxin, and neither protein had detectable basal (unactivated) enzymatic activity (data not shown). The 40,000-dalton fragment present in the preparation before purification on the FPLC sizing column was shown to be highly active in ADP-ribosylating elongation factor 2 (data not shown).
Cytotoxicity. (Fig. 2) . The difference in cytotoxicity between wild-type and mutant toxins was the same when crude extracts, partially purified forms of the toxins, or fully purified toxin preparations were compared. This finding shows that the extracts contained no N-terminal fragments active in blocking binding of the mutant toxin to the cellular receptors and that the cytotoxic activity of the mutant protein was not altered during the purification process. Toxin in extracts or partially purified toxin was quantified as described in Materials and Methods.
When the cytotoxicity of the mutant toxin was assayed in the absence of serum, the ID50 (toxin concentration reducing protein synthesis 50%) was decreased approximately threefold (data not shown). This was not observed with wild-type toxin. The addition of leupeptin, phenylmethylsulfonyl fluoride, and trypsin inhibitor also decreased slightly the ID50 of the mutant protein in the presence of serum (data not shown). This finding suggests that there may be partial inactivation of the mutant toxin during the incubation by proteases present in the serum.
The decreased cytotoxicity of the mutant toxin can possibly be explained by decreased stability. Before and during purification, the protein was rapidly cleaved into several fragments even in the presence of protease inhibitors. It was recently reported that degradation of proteins takes place within endosomes because of the presence of proteolytic enzymes such as cathepsin D (5), cathepsin B (21, 26) , and carboxypeptidase (23) .
Effect of low pH on the conformation of Ser-265/Ser-287 ETA. Sandvig and Moskaug (22) have shown that ETA binds Triton X-114 at pH values below 5.0. Triton X-114 is a nonionic detergent that is miscible with water at 0°C, whereas two phases are formed at temperatures above 20°C. When proteins are added to the detergent at low temperature and the mixture is incubated at 37°C, hydrophilic proteins are enriched in the detergent-poor phase, whereas amphiphilic proteins are partitioned into the detergent phase (2) . The finding of Sandvig and Moskaug (22) implies that cryptic hydrophobic regions of ETA become exposed at low pH. This, in turn, suggests that the demonstrated requirement for low pH during the entry process is to facilitate the transport of the toxin across the vesicular membrane by rendering the molecule hydrophobic. It is highly unlikely that ETA in its native hydrophilic form would be able to penetrate a lipid bilayer membrane.
We examined the detergent binding of mutant and wildtype ETAs as a function of pH. Wild-type and mutant ETAs were added to Triton X-114 at 4°C. The two phases were separated after incubation at 37°C, and the amount of toxin in the water phase was determined by assaying cytotoxicity. The percentage of toxin in the Triton phase at the different pH values was calculated as percentage of total toxin added. For both toxins, the titration curve was sharp (Fig. 3) . The mutant toxin entered the Triton phase at a higher pH (ca. 0.25 pH units) than did wild-type toxin. Control experiments showed that both the wild-type and mutant toxins retained cytotoxic activity after being exposed to the low pH required for detergent binding.
Partition of label into the detergent-rich and -poor phases was also determined by using 1251I-labeled toxins. lodinated wild-type ETA entered the detergent phase essentially as shown for noniodinated toxin (Fig. 3) . In contrast to wildtype ETA, the mutant toxin showed a gradual increase in the partition into the detergent phase as a function of decreasing perhaps some other uncharacterized acid-independent mechanism. As a percentage of the total, however, the amount of toxin entering via acid-independent pathways is minimal (9, 24) . To show that incubation of cells with NH4Cl did not interfere with the binding of either form of the toxin to cellular receptors, the following experiment was performed. NH4Cl was added to cells at 370C, and the cells were incubated for 15 min before being chilled on ice. Mutant and wild-type toxins were added at 4°C and incubated with the cells for 60 min. The cells were then washed and finally incubated further in ordinary medium without NH4C1 for 6 h at 37°C. In this case there was no effect of NH4C1 (data not shown).
The observation that NH4C1 has less effect on cytotoxicity of the mutant ETA than the wild-type ETA could be explained by the possibility that an increase in intravesicular pH due to the presence of NH4Cl stabilizes mutant ETA that would otherwise be susceptible to degradation or to unfolding, causing premature, abortive membrane insertion.
In conclusion, substitution of cysteines 265 and 287 in domain II of ETA by serines, thereby eliminating the disulfide bridge between helix A and helix B of this domain, yielded a mutant protein that was about 80-fold less toxic than wild-type toxin for mouse L cells. The ability of the protein to ADP ribosylate elongation factor 2, a function of domain III, was the same as for the wild-type protein; in addition, we doubt that the domain I function, binding of the toxin to cells, was significantly altered, although we were never able to obtain enough pure protein to do competition binding experiments under saturating conditions. The data presented are consistent with the notion that removal of the disulfide bridge alters the functional properties of domain II, causing either altered membrane permeation properties, a change in intracellular routing, or destabilization of the protein. Vol. 57, 1989 on October 28, 2017 by guest http://iai.asm.org/ Downloaded from
